X0306 4 2022-01-18 false 0001531048 Inari Medical, Inc. NARI 0001806431 Hykes Andrew C/O INARI MEDICAL, INC. 6001 OAK CANYON, SUITE 100 IRVINE CA 92618 false true false false Chief Operating Officer Common Stock 2022-01-18 4 S false 1224.00 75.462 D 156755.00 D Common Stock 2022-01-18 4 S false 1976.00 76.5818 D 154779.00 D Common Stock 2022-01-18 4 S false 1400.00 77.3119 D 153379.00 D Common Stock 2022-01-18 4 S false 400.00 78.2908 D 152979.00 D Common Stock 1550.00 I By Child 2 Common Stock 1550.00 I By Child 1 Common Stock 1550.00 I By Child 3 Common Stock 1000.00 I By Spouse The transactions reported in this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted by the reporting person on September 14, 2021. This transaction was executed in multiple trades at prices ranging from $74.98 to $75.96. The price reported above reflects the weighted average price. The reporting person hereby undertakes to provide upon request to the SEC staff, the issuer or a security holder of the issuer full information regarding the number of shares and prices at which the transaction was effected. This transaction was executed in multiple trades at prices ranging from $76.05 to $77.03. The price reported above reflects the weighted average price. The reporting person hereby undertakes to provide upon request to the SEC staff, the issuer or a security holder of the issuer full information regarding the number of shares and prices at which the transaction was effected. This transaction was executed in multiple trades at prices ranging from $77.05 to $77.90. The price reported above reflects the weighted average price. The reporting person hereby undertakes to provide upon request to the SEC staff, the issuer or a security holder of the issuer full information regarding the number of shares and prices at which the transaction was effected. This transaction was executed in multiple trades at prices ranging from $78.15 to $78.58. The price reported above reflects the weighted average price. The reporting person hereby undertakes to provide upon request to the SEC staff, the issuer or a security holder of the issuer full information regarding the number of shares and prices at which the transaction was effected. This amount reflects an updated holding to correct a typographical error in the total on a prior report. It also includes 695 shares acquired under the Employee Stock Ownership Plan in 2021. /s/ Angela Ahmad, attorney-in-fact for Andrew Hykes 2022-01-20